Riluzole as an Adjunctive Therapy to Risperidone for the Treatment of Irritability in Children with Autistic Disorder: A Double-Blind, Placebo-Controlled, Randomized Trial
Ali Ghaleiha(Hamedan University of Medical Sciences), Shahin Akhondzadeh(Arak University of Medical Sciences), Habibeh Yekehtaz(Arak University of Medical Sciences), Amirhossein Modabbernia(Icahn School of Medicine at Mount Sinai), Mehdi Farokhnia(National Institutes of Health), Mandana Ashrafi(Roozbeh Hospital), Effat Mohammadi(Roozbeh Hospital), Mohammad-Reza Mohammadi(Roozbeh Hospital), Elmira Hassanzadeh(Roozbeh Hospital)
Cited by 70
Related Papers
Environmental risk factors for autism: an evidence-based review of systematic reviews and meta-analyses
|Molecular Autism|2017|793
The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmission
|JCI Insight|2023|200
Sex Differences in Opioid and Psychostimulant Craving and Relapse: A Critical Review
|Pharmacological Reviews|2022|155
N-Acetylcysteine as an Adjunct to Risperidone for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia
|Clinical Neuropharmacology|2013|154
Comparing the efficacy and safety of<i>Crocus sativus</i>L. with memantine in patients with moderate to severe Alzheimer's disease: a double-blind randomized clinical trial
|Human Psychopharmacology Clinical and Experimental|2014|151